<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0406245391
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AERIALLERG 5MG FILM COATED TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DESLORATADINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        16.75
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharma International Co." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 513]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI ARABIAN DRUG STORE COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R06AX27 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Aeriallerg&reg; is<br />Aeriallerg&reg; contains desloratadine which is an antihistamine.<br />How Aeriallerg&reg; works<br />Aeriallerg&reg; is an antiallergy medicine that does not make you drowsy. It helps<br />control your allergic reaction and its symptoms.<br />When Aeriallerg&reg; should be used<br />Aeriallerg&reg; relieves symptoms associated with allergic rhinitis (inflammation<br />of the nasal<br />passages caused by an allergy, for example, hay fever or allergy to dust mites)<br />in adults and adolescents 12 years of age and older. These symptoms include<br />sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes.<br />Aeriallerg&reg; is also used to relieve the symptoms associated with urticaria (a skin<br />condition caused by an allergy). These symptoms include itching and hives.<br />Relief of these symptoms lasts a full day and helps you to resume your normal<br />daily activities and sleep.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Aeriallerg&reg;<br />&bull; if you are allergic to desloratadine, or to any of the other ingredients of this<br />medicine or to loratadine.<br />Warnings and precautions<br />Talk to your doctor, pharmacist or nurse before taking Aeriallerg&reg;:<br />- If you have poor kidney function.<br />Use in children and adolescents<br />Do not give this medicine to children less than 12 year of age.<br />Other medicines and Aeriallerg&reg;<br />There are no known interactions of Aeriallerg&reg; with other medicines. Tell your<br />doctor or pharmacist if you are taking, have recently taken or might take any<br />other medicines.<br />Aeriallerg&reg; with food, drink and alcohol<br />Aeriallerg&reg; may be taken with or without a meal.<br />Use caution when taking Aeriallerg&reg; with alcohol.<br />Pregnancy, breast-feeding and fertility<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning<br />to have a baby, ask your doctor or pharmacist for advice before taking this<br />medicine.<br />Taking Aeriallerg&reg; is not recommended if you are pregnant or nursing a baby.<br />Fertility<br />There is no data available on male/female fertility.<br />Driving and using machines<br />At the recommended dose, this medicine is not expected to affect your ability<br />to drive or use machines. Although most people do not experience drowsiness,<br />it is recommended not to engage in activities requiring mental alertness, such<br />as driving a car or operating machinery until you have established your own<br />response to the medicinal product.<br />Aeriallerg&reg; tablets contain Mannitol<br />Aeriallerg&reg; tablets contain Mannitol. If you have been told by your doctor that<br />you have an intolerance to some sugars, contact your doctor before taking this<br />medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you.<br />Check with your doctor or pharmacist if you are not sure.<br />Adults and adolescents 12 years of age and over<br />The recommended dose is one tablet once a day with water, with or without<br />food.<br />This medicine is for oral use.<br />Swallow the tablet whole.<br />Regarding the duration of treatment, your physician will determine the type<br />of allergic rhinitis you are suffering from and will determine for how long you<br />should take Aeriallerg&reg;.<br />If your allergic rhinitis is intermittent (presence of symptoms for less than 4<br />days per week or for less than 4 weeks), your physician will recommend you<br />a treatment schedule that will depend on the evaluation of the history of your<br />disease.<br />If your allergic rhinitis is persistent (presence of symptoms for 4 days or more<br />per week and for more than 4 weeks), your physician may recommend you a<br />longer term treatment.<br />For urticaria, the duration of treatment may be variable from patient to patient<br />and therefore you should follow the instructions of your physician.<br />If you take more Aeriallerg&reg; than you should<br />Take Aeriallerg&reg; only as it is prescribed for you. No serious problems are<br />expected with accidental overdose. However, if you take more Aeriallerg&reg; than<br />you were told to, tell your doctor, pharmacist or nurse immediately.</p><p>If you forget to take Aeriallerg&reg;<br />If you forget to take your dose on time, take it as soon as possible and then go<br />back to your regular dosing schedule. Do not take a double dose to make up for<br />a forgotten dose.<br />If you stop taking Aeriallerg&reg;<br />If you have any further questions on the use of this medicine, ask your doctor,<br />pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody<br />gets them.<br />During the marketing of desloratadine, cases of severe allergic reactions<br />(difficulty in breathing, wheezing, itching, hives and swelling) have been<br />reported very rarely. If you notice any of these serious side effects, stop taking the<br />medicine and seek urgent medical advice straight away.<br />In clinical studies in adults, side effects were about the same as with a dummy<br />tablet. However, fatigue, dry mouth and headache were reported more often than<br />with a dummy tablet. In adolescents, headache was the most commonly reported<br />side effect.<br />In clinical studies with desloratadine, the following side effects were reported as:<br />Common: the following may affect up to 1 in 10 people<br />● fatigue<br />● dry mouth<br />● headache<br />Adults<br />During the marketing of desloratadine, the following side effects were reported<br />as:<br />Very rare: the following may affect up to 1 in 10,000 people<br />● severe allergic reactions<br />● rash<br />● pounding or irregular heartbeat<br />● fast heartbeat<br />● stomach ache<br />● feeling sick (nausea)<br />● vomiting<br />● upset stomach<br />● diarrhea<br />● dizziness<br />● drowsiness<br />● inability to sleep<br />● muscle pain<br />● hallucinations<br />● seizures<br />● restlessness with increased body movement<br />● liver inflammation<br />● abnormal liver function tests<br />Not known: frequency cannot be estimated from the available data<br />● unusual weakness<br />● yellowing of the skin and/or eyes<br />● increased sensitivity of the skin to the sun, even in case of hazy sun, and to UV<br />light, for instance to UV lights of a solarium<br />● change in the way the heart beats<br />Children<br />Not known: frequency cannot be estimated from the available data<br />● slow heartbeat<br />● change in the way the heart beats<br />If you get any side effects, talk to your doctor, pharmacist or nurse. This<br />includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Do not use Aeriallerg&reg; after the expiry date (EXP) which is stated on the blister<br />and the carton.<br />The expiry date refers to the last day of that month.<br />Aeriallerg&reg; Tablets: Store below 30&deg;C.<br />Medicines should not be disposed of via wastewater or household waste. Ask<br />your pharmacist how to dispose of medicines no longer required. These measures<br />will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is desloratadine.<br />The other ingredients are Mannitol spray dried, microcrystalline cellulose, sodium<br />starch glycolate, colloidal silicon dioxide, magnesium stearate, Opadry OY-L<br />White, FD&amp;C Blue #1 lake, FD&amp;C Red #40 lake, Polyethylene glycol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Aeriallerg® 5mg F/C tablets: Light purple round shallow biconvex beveled
film coated tablet engraved with PhI on one face, presented in Alu/ Alu blisters,
intended for oral use.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharma International Company<br />Amman - Jordan<br />Tel: 00962-6-5158890 / 5157893<br />Fax: 00962-6-5154753<br />Email: marketing@pic-jo.com<br />This leaflet does not contain all the information about your medicine. If you have<br />any questions or are not sure about anything, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 06/2017
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>&nbsp;</p><p>ما هو إيرياليرج</p><p>يحتوي إيرياليرج&reg; &nbsp;على ديسلوراتادين والذي يعد أحد مضادات الهيستامين.</p><p>&reg; كيفية عمل إيرياليرج<br />يعد إيرياليرج&reg; دواء مضاد للتحسس الذي لا يسبب لك النعاس. ويساعد في ضبط التفاعل التحسسي<br />وأعراضه.<br />دواعي استعمال إيرياليرج&reg;<br />يعمل إيرياليرج&reg; على تخفيف الأعراض المرتبطة بالتفاعل التحسسي الأنفي )التهاب الممرات الأنفية<br />الناتج عن التحسس، مثل حمى القش أو التحسس لعث الغبار( عند البالغين المراهقين الذين تبلغ<br />أعمارهم 12 عاما و أكثر. تتضمن هذه الأعراض عطاس، سيلان أو حكة في الأنف، حكة في الفك،<br />وحكة في العيون، احمرارها وتدمعها.<br />يستعمل إيرياليرج&reg; أيضا لتخفيف الأعراض المرتبطة بالشرى (حالة جلدية ناتجة عن التحسس)<br />تتضمن هذه الأعراض حكة وشرى.<br />يستمر تخفيف هذه الأعراض ليوم كامل ويساعد ذلك في إعادة القدرة على ممارسة نشاطاتك اليومية<br />الطبيعية والنوم بشكل طبيعي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>الحالات التي يجب أن لا تتناول فيها إيرياليرج<br />&bull; إذا كنت تعاني من تحسس لديسلوراتادين أو لأي من المكونات الأخرى في هذا الدواء أو تحسس<br />للوراتادين.<br />المحاذير والاحتياطات:<br />:&reg; تحدث مع طبيبك، الصيدلي أو الممرض قبل تناول إيرياليرج<br />&bull; إذا كنت تعاني من قصور في وظيفة الكلى.<br />الاستعمال للأطفال والمراهقين<br />لا يعطى هذا الدواء للأطفال الذين تقل أعمارهم عن 12 عاما.<br />&reg; تناول أدوية أخرى مع إيرياليرج<br />مع الأدوية الأخرى. أخبر طبيبك أو الصيدلي إذا كنت تتناول، &reg; لا يوجد تفاعلات معروفة لإيرياليرج<br />تناولت مؤخرا أو من الممكن أن تتناول أي أدوية أخرى.</p><p>مع الطعام، الشراب والكحول &reg;</p><p>من الممكن تناول إيرياليرج مع أو بدون تناول الطعام. &reg;</p><p>توخى الحذر عند تناول إيرياليرج مع شرب الكحول. &reg;&nbsp;</p><p>&nbsp;</p><p>الحمل، الرضاعة الطبيعية والخصوبة</p><p>إذا كنت حاملا أو مرضعة، تعتقدين أنك حاملا أو تخططين للحمل، استشيري طبيبك أو الصيدلي<br />قبل تناول هذا الدواء.<br />إذا كنت حاملا أو مرضعة. &reg; لا يوصى بتناول إيرياليرج<br />الخصوبة<br />لا تتوفرمعلومات حول تأثير هذا الدواء على خصوبة الرجال/النساء.<br />القيادة و استخدام الآلات<br />عند تناول الجرعة الموصى بها، من غير المتوقع أن يؤثر هذا الدواء على قدرتك على القيادة أو<br />استخدام الآلات. على الرغم من أن معظم الأشخاص لا يعانون من شعور بالنعاس، لكن يوصى بعدم<br />القيام بنشاطات تحتاج إلى يقظة عقلية، مثل القيادة أو تشغيل الآلات إلى أن تتمكن من معرفة كيفية<br />تأثير هذا الدواء عليك.<br />&reg; تحتوي أقراص إيرياليرج على مانيتول&nbsp;<br />&reg; تحتوي أقراص إيرياليرج على مانيتول. إذا أخبرت من قبل الطبيب أنك لا تستطيع تحمل بعض<br />أنواع السكريات، اتصل مع الطبيب قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دائما تناول هذا الدواء تماما كما أخبرك طبيبك أو الصيدلي. يجب عليك التحقق من طبيبك أو الصيدلي<br />إذا لم تكن متأكدا من كيفية استخدام الدواء.<br />البالغون والمراهقون الذين تبلغ أعمارهم 12 عاما وأكثر<br />الجرعة الموصى بها هي قرص واحد مرة واحدة يوميا مع شرب الماء، مع أو بدون تناول الطعام.<br />هذا الدواء معد للاستعمال عن طريق الفم.<br />قم بتناول القرص كاملا.<br />فيما يتعلق بمدة العلاج، سيقوم الطبيب بتحديد نوع التحسس الأنفي الذي تعاني منه و سوف يحدد المدة<br />&nbsp;التي يجب أن تتناول خلالها إيرياليرج<br />إذا كنت تعاني من تحسس أنفي غير مستمر )على فترات متقطعة( )ظهور الأعراض لمدة تقل عن<br />4 أيام من كل أسبوع أو لمدة تقل عن 4 أسابيع(، سيوصي الطبيب بنظام علاجي يعتمد على تقييم<br />تاريخ المرض لديك.<br />إذا كنت تعاني من تحسس أنفي مستمر )ظهور الأعراض لمدة 4 أيام أو أكثر من كل أسبوع و لمدة<br />تزيد عن 4 أسابيع(، قد يوصي الطبيب بعلاجك لمدة أطول.<br />لعلاج الشرى، قد تختلف مدة العلاج من مريض لآخر و لذلك يجب عليك اتباع تعليمات طبيبك.<br />إذا تناولت إيرياليرج أكثر مما يجب&nbsp;<br />تناول إيرياليرج فقط كما وصفه الطبيب لك. من غير المتوقع حصول مشاكل خطيرة عند زيادة&nbsp; الجرعة عن طريق الخطأ<br />لكن، إذا تناولت أكثر مما يجب من إيرياليرج أخبر الطبيب، الصيدلي ,أو الممرض فورا.<br />&reg; إذا نسيت تناول جرعة إيرياليرج<br />إذا نسيت تناول جرعة في وقتها المحدد، تناولها حال تذكرك، ثم تناول جرعتك التالية في وقتها<br />المعتاد. لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيتها.<br />&reg; إذا توقفت عن تناول إيرياليرج<br />إذا كان لديك أية أسئلة إضافية عن استعمال هذا الدواء، اسأل طبيبك، الصيدلي أو الممرض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن أن يتسبب هذا الدواء في آثار جانبية، على الرغم من أنها لا تحصل عند<br />الجميع.<br />خلال فترة تسويق ديسلوراتادين، تم تسجيل حدوث حالات من تفاعلات تحسسية حادة بشكل نادر جدا<br />(صعوبة في التنفس، أزيز تنفسي، حكة، شرى وتورم)</p><p>إذا لاحظت حدوث أي من هذه الآثار الجانبية<br />الخطيرة، توقف عن تناول هذا الدواء واطلب النصيحة الطبية الطارئة فورا.<br />في الدراسات السريرية على البالغين، كانت الآثار الجانبية عند استعمال ديسلوراتادين مشابهة لتلك التي<br />ظهرت عند استعمال الأقراص بدون المادة الفعالة. لكن، تم تسجيل الآثار الجانبية التالية عند استعمال<br />الأقراص بدون المادة الفعالة والتي تتضمن شعور بالتعب، جفاف الفم و صداع. ويعد الصداع الأثر<br />الجانبي الأكثر شيوعا التي تم تسجيله عند المراهقين.<br />في الدراسات السريرية المتعلقة باستعمال ديسلوراتادين تم تسجيل حدوث الآثار الجانبية التالية:<br />شائعة: الآثار الجانبية التالية قد تؤثر على 1 أو أقل من كل 10 أشخاص<br />&bull; الشعور بالتعب.<br />&bull; جفاف الفم.<br />&bull; صداع.<br />البالغون<br />خلال فترة تسويق ديسلوراتادين، تم تسجيل حدوث الآثار الجانبية التالية:<br />نادرة جدا: الآثار الجانبية التالية قد تؤثر على 1 أو أقل من كل 10000 شخص<br />&bull; تفاعلات تحسسية حادة.<br />&bull; طفح.<br />&bull; نبضات قلب قوية وسريعة أو غير منتظمة.<br />&bull; نبضات قلب سريعة.<br />&bull; ألم في المعدة.<br />&bull; شعور بالغثيان.<br />&bull; قيء.<br />&bull; اضطراب في المعدة.<br />&bull; إسهال.<br />&bull; شعور بالدوار.<br />&bull; شعور بالنعاس.<br />&bull; عدم القدرة على النوم.<br />&bull; ألم في العضلات.<br />&bull; هلوسات.<br />&bull; نوبات صرع.<br />&bull; شعور بعدم الراحة مع زيادة حركة الجسم.<br />&bull; التهاب الكبد.<br />&bull; اضطراب نتائج فحوصات وظيفة الكبد.<br />غير معروفة: لا يمكن تقدير تكرار حدوثها من المعلومات المتوفرة<br />&bull; تعب غير المعتاد.<br />&bull; اصفرار الجلد و/أو المنطقة البيضاء في العيون.<br />&bull; زيادة تحسس الجلد لأشعة الشمس، حتى في حالة الشمس الغائمة (الضبابية)و الأشعة فوق البنفسجية،<br />مثل التعرض للأشعة فوق البنفسجية من خلال الأجهزة التي تعمل على زيادة اسمرار لون الجلد.<br />&bull; تغير في طريقة نبضات القلب.<br />الأطفال<br />غير معروفة: لا يمكن تقدير تكرار حدوثها من المعلومات المتوفرة<br />&bull; نبضات القلب بطيئة.<br />&bull; تغير في طريقة نبضات القلب.<br />إذا حصل لديك أي من الآثار الجانبية، تحدث مع طبيبك، الصيدلي أو الممرض. هذا يتضمن أي آثار<br />جانبية غير مذكورة في هذه النشرة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيدا عن متناول الأطفال و نظرهم.<br />&reg; لا تستخدم إيرياليرج بعد تاريخ انتهاء الصلاحية المذكورعلى الشريط و العلبة الخارجية.&nbsp;<br />تاريخ الانتهاء يشير إلى اليوم الأخير من ذلك الشهر.<br />&reg; إيرياليرج أقراص: يحفظ بدرجة حرارة دون &deg; 30 م.&nbsp;<br />يجب أن لا يتم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل<br />الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي ديسلوراتادين.<br />المكونات الأخرى هي رذاذ المانيتول المجفف، ميكروكريستالين سيليلوز، جلايكولات نشا الصوديوم،<br />&nbsp;ثاني أكسيد السيليكون الغروي، ستيرات المغنيسيوم، أوبادري أبيض، لون أزرق رقم 1FD&amp;C</p><p>لون احمر رقم FD&amp;C-40 ,بولي إيثيلين جلايكول .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>&reg; أقراص إيرياليرج 5 ملغم: أقراص مغلفة دائرية الشكل ذات لون أرجواني فاتح، محدبة الوجهين،<br />معبأة في أشرطة ألومنيوم/ألومنيوم، معدة للاستعمال عن طريق الفم. محفور على أحد الأوجه&nbsp;،PhI<br />حجم العبوة<br />30 قرصا. (10 أقراص/شريط، 3 أشرطة/عبوة).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة الدولية للدواء<br />عمان - الأردن</p><p>00962 - 6 - 5158890 /&nbsp; 5157893 :هاتف<br />00962 - 6 -&nbsp; 5154753 :فاكس<br />marketing@pic-jo.com : البريد الإلكتروني<br />هذه النشرة لا تحتوي على جميع المعلومات عن المستحضر. إذا كان لديك أية أسئلة أو لم تكن متأكدا<br />من أي شيء، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم تنقيح هذه النشرة في 06/2017
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aeriallerg® F/C Tablets.
Desloratadine 5 mg F/C Tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aeriallerg® 5mg F/C tablets: Each tablet contains 5mg Desloratadine.
For a full list of excipients: see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aeriallerg® 5mg F/C tablets: Light purple round shallow biconvex beveled film coated tablet engraved with PhI on one face, presented in Alu/ Alu blisters, intended for oral use.
Pack size: 30 tablets (10 tablets/Blister/3 Blisters/Pack)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Aeriallerg&reg; is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Posology</p><p style="text-align:left">Adults and adolescents (12 years of age and over) The recommended dose of Aeriallerg&reg; is one tablet once a day. Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient&#39;s disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance. In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure periods. Paediatric population There is limited clinical trial efficacy experience with the use of desloratadine in adolescents 12 through 17 years of age (see sections 4.8 and 5.1). The safety and efficacy of Aeriallerg&reg; 5 mg film-coated tablets in children below the age of 12 years have not been established. No data are available. Method of administration<br />Oral use. The dose can be taken with or without food.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to any of the excipients listed in section 6.1, or to loratadine.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">In the case of severe renal insufficiency, Aeriallerg&reg; should be used with caution (see section 5.2). Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">No clinically relevant interactions were observed in clinical trials with desloratadine tablets in which erythromycin or ketoconazole were co-administered (see section 5.1). Paediatric population Interaction studies have only been performed in adults. In a clinical pharmacology trial, Aeriallerg&reg; tablets taken concomitantly with alcohol did not potentiate the performance impairing effects of alcohol (see section 5.1). However, cases of alcohol intolerance and intoxication have been reported during post-marketing use. Therefore, caution is recommended if alcohol is taken concomitantly.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Pregnancy</p><p style="text-align:left">A large amount of data on pregnant women (more than 1,000 pregnancy outcomes) indicate no malformative nor foeto/neonatal toxicity of desloratadine. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3). As a precautionary measure, it is preferable to avoid the use of Aeriallerg&reg; during pregnancy.</p><p style="text-align:left">Breast-feeding</p><p style="text-align:left">Desloratadine has been identified in breastfed newborns/infants of treated women. The effect of desloratadine on newborns/infants is unknown. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Aeriallerg&reg; therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.</p><p style="text-align:left">Fertility</p><p style="text-align:left">There are no data available on male and female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Aeriallerg&reg; has no or negligible influence on the ability to drive and use machines based on clinical trials. Patients should be informed that most<br />people do not experience drowsiness. Nevertheless, as there is individual variation in response to all medicinal products, it is recommended that patients are advised not to engage in activities requiring mental alertness, such as driving a car or using machines, until they have established their own response to the medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:15.1pt; margin-right:0cm; text-align:left"><u>Summary of the safety profile</u></p><p style="margin-left:15.1pt; margin-right:18.1pt; text-align:left">In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with desloratadine were reported in 3 % of patients in excess of those treated with placebo. The most frequent of adverse reactions reported in excess of placebo were fatigue (1.2 %), dry mouth (0.8 %) and headache (0.6 %).</p><p style="margin-left:15.1pt; margin-right:0cm; text-align:left"><u>Paediatric population</u></p><p style="margin-left:15.1pt; margin-right:18.1pt; text-align:left">In a clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common adverse event was headache; this occurred in 5.9 % of patients treated with desloratadine and 6.9 % of patients receiving placebo.</p><p style="margin-left:15.1pt; text-align:left"><u>Tabulated list of adverse reactions</u></p><p style="margin-left:15.1pt; margin-right:17.65pt; text-align:left">The frequency of the clinical trial adverse reactions reported in excess of placebo and other undesirable effects reported during the post-marketing period are listed in the following table. Frequencies are defined as very common (&ge; 1/10), common (&ge; 1/100 to &lt; 1/10), uncommon (&ge; 1/1,000 to &lt; 1/100), rare (&ge; 1/10,000 to &lt; 1/1,000), very rare (&lt; 1/10,000) and not known (cannot be estimated from the available data).</p><p style="margin-left:0cm; margin-right:0cm; text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:black; height:30.55pt; vertical-align:top; width:112.45pt"><p style="margin-left:1.5pt; margin-right:27.8pt; text-align:left"><strong>System Organ Class</strong></p></td><td style="border-color:black; height:30.55pt; vertical-align:top; width:72.1pt"><p style="margin-left:1.55pt; margin-right:0cm; text-align:left"><strong>Frequency</strong></p></td><td style="border-color:black; height:30.55pt; vertical-align:top; width:225.05pt"><p style="margin-left:1.55pt; margin-right:59.65pt; text-align:left"><strong>Adverse reactions seen with desloratadine</strong></p></td></tr><tr><td style="border-color:black; height:30.55pt; vertical-align:top; width:112.45pt"><p style="margin-left:1.5pt; margin-right:45.15pt; text-align:left"><strong>Psychiatric disorders</strong></p></td><td style="height:30.55pt; vertical-align:top; width:72.1pt"><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Very rare</p></td><td style="height:30.55pt; vertical-align:top; width:225.05pt"><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Hallucinations</p></td></tr><tr><td style="border-color:black; height:44.35pt; vertical-align:top; width:112.45pt"><p style="margin-left:1.5pt; margin-right:16.45pt; text-align:left"><strong>Nervous system disorders</strong></p></td><td style="height:44.35pt; vertical-align:top; width:72.1pt"><p style="margin-left:1.55pt; margin-right:19.45pt; text-align:left">Common Very rare</p></td><td style="height:44.35pt; vertical-align:top; width:225.05pt"><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Headache</p><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Dizziness, somnolence, insomnia, psychomotor hyperactivity, seizures</p></td></tr><tr><td style="border-color:black; height:30.6pt; vertical-align:top; width:112.45pt"><p style="margin-left:1.5pt; margin-right:0cm; text-align:left"><strong>Cardiac disorders</strong></p></td><td style="height:30.6pt; vertical-align:top; width:72.1pt"><p style="margin-left:1.55pt; margin-right:12.1pt; text-align:left">Very rare Not known</p></td><td style="height:30.6pt; vertical-align:top; width:225.05pt"><p style="margin-left:1.55pt; margin-right:89pt; text-align:left">Tachycardia, palpitations QT prolongation</p></td></tr><tr><td style="border-color:black; height:44.45pt; vertical-align:top; width:112.45pt"><p style="margin-left:1.5pt; margin-right:17.8pt; text-align:left"><strong>Gastrointestinal disorders</strong></p></td><td style="height:44.45pt; vertical-align:top; width:72.1pt"><p style="margin-left:1.55pt; margin-right:19.45pt; text-align:left">Common Very rare</p></td><td style="height:44.45pt; vertical-align:top; width:225.05pt"><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Dry mouth</p><p style="margin-left:1.55pt; margin-right:38.3pt; text-align:left">Abdominal pain, nausea, vomiting, dyspepsia, diarrhoea</p></td></tr><tr><td style="border-color:black; height:44.35pt; vertical-align:top; width:112.45pt"><p style="margin-left:1.5pt; margin-right:33.15pt; text-align:left"><strong>Hepatobiliary disorders</strong></p></td><td style="height:44.35pt; vertical-align:top; width:72.1pt"><p style="margin-left:1.55pt; margin-right:12.1pt; text-align:left">Very rare Not known</p></td><td style="height:44.35pt; vertical-align:top; width:225.05pt"><p style="margin-left:1.55pt; margin-right:17.65pt; text-align:left">Elevations of liver enzymes, increased bilirubin, hepatitis</p><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Jaundice</p></td></tr><tr><td style="border-color:black; height:44.35pt; vertical-align:top; width:112.45pt"><p style="margin-left:1.5pt; margin-right:16.45pt; text-align:left"><strong>Skin and subcutaneous tissue disorders</strong></p></td><td style="height:44.35pt; vertical-align:top; width:72.1pt"><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Not known</p></td><td style="height:44.35pt; vertical-align:top; width:225.05pt"><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Photosensitivity</p></td></tr><tr><td style="border-color:black; height:14.6pt; vertical-align:top; width:112.45pt"><p style="margin-left:1.5pt; margin-right:0cm; text-align:left"><strong>Musculoskeletal</strong></p></td><td style="height:14.6pt; vertical-align:top; width:72.1pt"><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Very rare</p></td><td style="height:14.6pt; vertical-align:top; width:225.05pt"><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Myalgia</p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:black; height:30.55pt; vertical-align:top; width:112.45pt"><p style="margin-left:1.5pt; margin-right:16.45pt; text-align:left"><strong>and connective tissue disorders</strong></p></td><td style="border-color:black; height:30.55pt; vertical-align:top; width:72.1pt"><p style="margin-left:0cm; margin-right:0cm; text-align:left">&nbsp;</p></td><td style="border-color:black; height:30.55pt; vertical-align:top; width:225.05pt"><p style="margin-left:0cm; margin-right:0cm; text-align:left">&nbsp;</p></td></tr><tr><td style="border-color:black; height:71.95pt; vertical-align:top; width:112.45pt"><p style="margin-left:1.5pt; margin-right:1.85pt; text-align:left"><strong>General disorders and administration site conditions</strong></p></td><td style="height:71.95pt; vertical-align:top; width:72.1pt"><p style="margin-left:1.55pt; margin-right:12.1pt; text-align:left">Common Very rare Not known</p></td><td style="height:71.95pt; vertical-align:top; width:225.05pt"><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Fatigue</p><p style="margin-left:1.55pt; margin-right:23.6pt; text-align:left">Hypersensitivity reactions (such as anaphylaxis, angioedema, dyspnoea, pruritus, rash, and urticaria)</p><p style="margin-left:1.55pt; margin-right:0cm; text-align:left">Asthenia</p></td></tr></tbody></table><p style="margin-left:15.1pt; margin-right:0cm; text-align:left"><u>Paediatric population</u></p><p style="margin-left:15.1pt; margin-right:17.95pt; text-align:left">Other undesirable effects reported during the post-marketing period in paediatric patients with an unknown frequency included QT prolongation, arrhythmia, and bradycardia.</p><p style="margin-left:0cm; margin-right:0cm; text-align:left">&nbsp;</p><p style="text-align:left">To report any side effect(s):</p><p style="text-align:left">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>Saudi Arabia:</strong></p><p style="text-align:left">-&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance and Drug Safety Center (NPC) Fax: +966-11-205-7662</p><p style="margin-left:47pt; margin-right:0cm; text-align:left; text-indent:-18.05pt">Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p style="margin-left:47pt; margin-right:0cm; text-align:left; text-indent:-18.05pt">Toll free phone: 8002490000 E-mail: <u>npc.drug@sfda.gov.sa</u></p><p style="margin-left:47pt; margin-right:0cm; text-align:left; text-indent:-18.05pt">o Website: <u>www.sfda.gov.sa/npc</u></p><p style="margin-left:47pt; margin-right:0cm; text-align:left; text-indent:-18.05pt">&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Other GCC States:</p><p style="margin-left:29pt; margin-right:0cm; text-align:left">Please contact the relevant competent authority.</p><p style="margin-left:0cm; margin-right:0cm">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:21.05pt; margin-right:21.8pt; text-align:left">The adverse event profile associated with overdosage, as seen during post- marketing use, is similar to that seen with therapeutic doses, but the magnitude of the effects can be higher.</p><p style="text-align:left"><u>Treatment</u></p><p style="text-align:left">In the event of overdose, consider standard measures to remove unabsorbed active substance. Symptomatic and supportive treatment is recommended.</p><p style="margin-right:17.95pt; text-align:left">Desloratadine is not eliminated by haemodialysis; it is not known if it is eliminated by peritoneal dialysis.</p><p style="text-align:left"><u>Symptoms</u></p><p style="margin-right:22pt; text-align:left">Based on a multiple dose clinical trial, in which up to 45 mg of desloratadine was administered (nine times the clinical dose), no clinically relevant effects were observed.</p><p style="text-align:left"><u>Paediatric population</u></p><p style="margin-right:21.8pt; text-align:left">The adverse event profile associated with overdosage, as seen during post- marketing use, is similar to that seen with therapeutic doses, but the magnitude of the effects can be higher.</p><p style="margin-left:0cm">&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Pharmacotherapeutic group: antihistamines &ndash; H<sub>1</sub> antagonist, ATC code:</p><p style="text-align:left">&nbsp;</p><p style="text-align:left">R06A X27</p><p style="text-align:left"><u>Mechanism of action</u></p><p style="margin-right:21.9pt; text-align:left">Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H<sub>1</sub>-receptor antagonist activity. After oral administration, desloratadine selectively blocks peripheral histamine H<sub>1</sub>-receptors because the substance is excluded from entry to the central nervous system.</p><p style="margin-right:21.8pt; text-align:left">Desloratadine has demonstrated antiallergic properties from <em>in vitro </em>studies. These include inhibiting the release of proinflammatory cytokines such as IL- 4, IL-6, IL-8, and IL-13 from human mast cells/basophils, as well as inhibition of the expression of the adhesion molecule P-selectin on endothelial cells. The clinical relevance of these observations remains to be confirmed.</p><p style="text-align:left"><u>Clinical efficacy and safety</u></p><p style="margin-right:21.85pt; text-align:left">In a multiple dose clinical trial, in which up to 20 mg of desloratadine was administered daily for 14 days, no statistically or clinically relevant cardiovascular effect was observed. In a clinical pharmacology trial, in which desloratadine was administered at a dose of 45 mg daily (nine times the clinical dose) for ten days, no prolongation of QTc interval was seen.</p><p style="margin-right:22.4pt; text-align:left">No clinically relevant changes in desloratadine plasma concentrations were observed in multiple-dose ketoconazole and erythromycin interaction trials.</p><p style="margin-right:21.85pt; text-align:left">Desloratadine does not readily penetrate the central nervous system. In controlled clinical trials, at the recommended dose of 5 mg daily, there was no excess incidence of somnolence as compared to placebo. desloratadine given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials. In a single dose study performed in adults, desloratadine 5 mg did not affect standard measures of flight performance including exacerbation of subjective sleepiness or tasks related to flying.</p><p style="margin-right:21.9pt; text-align:left">In clinical pharmacology trials, co-administration with alcohol did not increase the alcohol-induced impairment in performance or increase in sleepiness. No significant differences were found in the psychomotor test results between desloratadine and placebo groups, whether administered alone or with alcohol.</p><p style="margin-right:21.9pt; text-align:left">In patients with allergic rhinitis, desloratadine was effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate. desloratadine effectively controlled symptoms for 24 hours.</p><p style="text-align:left"><u>Paediatric population</u></p><p style="margin-right:22.15pt; text-align:left">The efficacy of desloratadine tablets has not been clearly demonstrated in trials with adolescent patients 12 through 17 years of age.</p><p style="margin-right:22.15pt; text-align:left">In addition to the established classifications of seasonal and perennial, allergic rhinitis can alternatively be classified as intermittent allergic rhinitis and persistent allergic rhinitis according to the duration of symptoms. Intermittent allergic rhinitis is defined as the presence of symptoms for less than 4 days per week or for less than 4 weeks. Persistent allergic rhinitis is defined as the presence of symptoms for 4 days or more per week and for more than 4 weeks.</p><p style="text-align:left">Desloratadine was effective in alleviating the burden of seasonal allergic</p><p style="text-align:left">&nbsp;</p><p style="margin-left:21.05pt; margin-right:21.95pt; text-align:left">rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire. The greatest amelioration was seen in the domains of practical problems and daily activities limited by symptoms.</p><p style="margin-right:21.85pt; text-align:left">Chronic idiopathic urticaria was studied as a clinical model for urticarial conditions, since the underlying pathophysiology is similar, regardless of etiology, and because chronic patients can be more easily recruited prospectively. Since histamine release is a causal factor in all urticarial diseases, desloratadine is expected to be effective in providing symptomatic relief for other urticarial conditions, in addition to chronic idiopathic urticaria, as advised in clinical guidelines.</p><p style="margin-left:21.05pt; margin-right:21.95pt; text-align:left">In two placebo-controlled six week trials in patients with chronic idiopathic urticaria, desloratadine was effective in relieving pruritus and decreasing the size and number of hives by the end of the first dosing interval. In each trial, the effects were sustained over the 24 hour dosing interval. As with other antihistamine trials in chronic idiopathic urticaria, the minority of patients who were identified as non-responsive to antihistamines was excluded. An improvement in pruritus of more than 50 % was observed in 55 % of patients treated with desloratadine compared with 19 % of patients treated with placebo. Treatment with desloratadine also significantly reduced interference with sleep and daytime function, as measured by a four-point scale used to assess these variables.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left"><u>Absorption</u></p><p style="margin-left:11pt; margin-right:11.7pt; text-align:left">Desloratadine plasma concentrations can be detected within 30 minutes of administration. Desloratadine is well absorbed with maximum concentration achieved after approximately 3 hours; the terminal phase half-life is approximately 27 hours. The degree of accumulation of desloratadine was consistent with its half-life (approximately 27 hours) and a once daily dosing frequency. The bioavailability of desloratadine was dose proportional over the range of 5 mg to 20 mg.</p><p style="margin-left:11pt; margin-right:11.8pt; text-align:left">In a pharmacokinetic trial in which patient demographics were comparable to those of the general seasonal allergic rhinitis population, 4 % of the subjects achieved a higher concentration of desloratadine. This percentage may vary according to ethnic background. Maximum desloratadine concentration was about 3-fold higher at approximately 7 hours with a terminal phase half-life of approximately 89 hours. The safety profile of these subjects was not different from that of the general population.</p><p style="margin-left:11pt; margin-right:0cm; text-align:left"><strong><u>Distribution</u></strong></p><p style="margin-left:11pt; margin-right:11.8pt; text-align:left">Desloratadine is moderately bound (83 % - 87 %) to plasma proteins. There is no evidence of clinically relevant medicine accumulation following once daily dosing of desloratadine (5 mg to 20 mg) for 14 days.</p><p style="margin-left:11pt; text-align:left"><strong><u>Biotransformation</u></strong></p><p style="margin-left:11pt; margin-right:11.7pt; text-align:left">The enzyme responsible for the metabolism of desloratadine has not been identified yet, and therefore, some interactions with other medicinal products cannot be fully excluded. Desloratadine does not inhibit CYP3A4 <em>in vivo, </em>and <em>in</em></p><p style="text-align:left">&nbsp;</p><p style="margin-left:11pt; margin-right:6.7pt; text-align:left"><em>vitro </em>studies have shown that the medicinal product does not inhibit CYP2D6 and is neither a substrate nor an inhibitor of P-glycoprotein.</p><p style="margin-left:11pt; text-align:left"><strong><u>Elimination</u></strong></p><p style="margin-left:11pt; margin-right:12.2pt; text-align:left">In a single dose trial using a 7.5 mg dose of desloratadine, there was no effect of food (high-fat, high caloric breakfast) on the disposition of desloratadine. In another study, grapefruit juice had no effect on the disposition of desloratadine.</p><p style="margin-left:11pt; text-align:left"><strong><u>Renally impaired patients</u></strong></p><p style="margin-left:11pt; margin-right:11.85pt; text-align:left">The pharmacokinetics of desloratadine in patients with chronic renal insufficiency (CRI) was compared with that of healthy subjects in one single-dose study and one multiple dose study. In the single-dose study, the exposure to desloratadine was approximately 2 and 2.5-fold greater in subjects with mild to moderate and severe CRI, respectively, than in healthy subjects. In the multiple-dose study, steady state was reached after Day 11, and compared to healthy subjects the exposure to desloratadine was ~1.5-fold greater in subjects with mild to moderate CRI and ~2.5-fold greater in subjects with severe CRI. In both studies, changes in exposure (AUC and C<sub>max</sub>) of desloratadine and 3-hydroxydesloratadine were not clinically relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:11.0pt; margin-right:11.75pt; text-align:justify">Desloratadine is the primary active metabolite of loratadine. Non-clinical studies conducted with desloratadine and loratadine demonstrated that there are no qualitative or quantitative differences in the toxicity profile of desloratadine and loratadine at comparable levels of exposure to desloratadine.</p><p style="margin-left:11.0pt; margin-right:12.0pt; text-align:justify">Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction and development. The lack of carcinogenic potential was demonstrated in studies conducted with desloratadine and loratadine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:11.0pt; margin-right:11.85pt; text-align:justify">Mannitol spray dried, microcrystalline cellulose, sodium starch glycolate, colloidal silicon dioxide, magnesium stearate, Opadry OY-L White, FD&amp;C Blue #1 lake, FD&amp;C Red #40 lake, polyethylene glycol.</p><p style="margin-left:0cm; margin-right:0cm">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:14.35pt; margin-right:0cm; text-align:justify">Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:11pt; margin-right:244.5pt; text-align:left; text-indent:0cm"><strong>Aeriallerg<sup>&reg;</sup> </strong>5mg: Store below 30&deg;C.</p><p style="margin-left:0cm">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:11.0pt; margin-right:11.95pt; text-align:justify"><strong>Aeriallerg<sup>&reg;</sup> </strong>5mg F/C tablets: Light purple round shallow biconvex beveled film coated tablet engraved with PhI on one face, presented in Alu/ Alu blisters, intended for oral use.</p><p style="margin-left:11.0pt; text-align:justify"><strong>Pack size: </strong>30 tablets (10 tablets/Blister/3 Blisters/Pack)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:15.3pt; margin-right:0cm; text-align:justify">No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pharma International Company Amman - Jordan
Tel: 00962-6-5158890 / 5157893
Fax: 00962-6-5154753
email: marketing@pic-jo.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                06/2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>